Health Catalyst Recognized as a Leader in Frost & Sullivan's 2024 US Population Health Management Report
Health Catalyst (Nasdaq: HCAT), a leading provider of data and analytics technology and services, has been recognized as a leader in the 2024 Frost Radar™: US Population Health Management report by Frost & Sullivan. The company was praised for its innovative Population Health suite, which offers financial and quality benchmarking tools, administrative support, and advanced analytics.
Frost & Sullivan analysts evaluated over 50 US companies in the PHM market based on their innovation and growth strategies. Health Catalyst was highlighted for revolutionizing third-party PHM IT initiatives with custom configurations, a pre-built rules engine, and superior data management capabilities.
CEO Dan Burton emphasized the company's commitment to addressing healthcare challenges through innovation and client-centric solutions, contributing to value-based care. The report also noted Health Catalyst's strategic acquisitions of Carevive and Lumeon, enhancing its oncology care management and patient communication capabilities.
Industry Analyst Sagar Mukhekar commended Health Catalyst's balanced focus on growth and innovation, customized solutions, and superior data management, positioning it as a leader in the PHM market. The company's expansion into underserved segments further solidifies its leadership.
Health Catalyst (Nasdaq: HCAT), un fornitore leader di tecnologia e servizi di data e analytics, è stato riconosciuto come leader nel rapporto 2024 Frost Radar™: Gestione della Salute della Popolazione negli Stati Uniti di Frost & Sullivan. L'azienda è stata lodata per la sua suite innovativa per la Salute della Popolazione, che offre strumenti di benchmark finanziari e di qualità, supporto amministrativo e analisi avanzate.
Gli analisti di Frost & Sullivan hanno valutato oltre 50 aziende statunitensi nel mercato della PHM in base alle loro strategie di innovazione e crescita. Health Catalyst è stata evidenziata per aver rivoluzionato le iniziative IT di PHM di terze parti con configurazioni personalizzate, un motore di regole pre-costruito e capacità di gestione dei dati superiori.
Il CEO Dan Burton ha sottolineato l'impegno dell'azienda nell'affrontare le sfide sanitarie attraverso l'innovazione e soluzioni incentrate sul cliente, contribuendo alla cura basata sul valore. Il rapporto ha inoltre notato le acquisizioni strategiche di Carevive e Lumeon da parte di Health Catalyst, che potenziano la gestione delle cure oncologiche e le capacità di comunicazione con i pazienti.
L'analista di settore Sagar Mukhekar ha lodato l'equilibrato focus di Health Catalyst su crescita e innovazione, soluzioni personalizzate e gestione superiore dei dati, posizionandola come leader nel mercato della PHM. L'espansione dell'azienda in segmenti sottoserviti rafforza ulteriormente la sua leadership.
Health Catalyst (Nasdaq: HCAT), un proveedor líder de tecnología y servicios de datos y análisis, ha sido reconocido como líder en el informe 2024 Frost Radar™: Gestión de la Salud de la Población en EE. UU. por Frost & Sullivan. La compañía fue elogiada por su innovador conjunto de herramientas de Salud de la Población, que ofrece herramientas de referencia financiera y de calidad, soporte administrativo y análisis avanzados.
Los analistas de Frost & Sullivan evaluaron más de 50 empresas estadounidenses en el mercado de la PHM en función de sus estrategias de innovación y crecimiento. Health Catalyst fue destacada por revolucionar las iniciativas de TI de PHM de terceros con configuraciones personalizadas, un motor de reglas preconstruido y capacidades superiores de gestión de datos.
El CEO Dan Burton enfatizó el compromiso de la empresa para abordar los desafíos de atención médica a través de la innovación y soluciones centradas en el cliente, contribuyendo a la atención basada en el valor. El informe también destacó las adquisiciones estratégicas de Carevive y Lumeon por parte de Health Catalyst, mejorando su gestión de atención oncológica y capacidades de comunicación con los pacientes.
El analista de la industria Sagar Mukhekar elogió el enfoque equilibrado de Health Catalyst en el crecimiento y la innovación, soluciones personalizadas y gestión superior de datos, posicionándola como líder en el mercado de la PHM. La expansión de la empresa en segmentos desatendidos refuerza aún más su liderazgo.
Health Catalyst (Nasdaq: HCAT), 데이터 및 분석 기술과 서비스의 선두 제공업체는 Frost & Sullivan의 2024 Frost Radar™: 미국 인구 건강 관리 보고서에서 리더로 인정받았습니다. 이 회사는 재정 및 품질 벤치마크 도구, 관리 지원, 고급 분석을 제공하는 혁신적인 인구 건강 관리 제품군으로 찬사를 받았습니다.
Frost & Sullivan의 분석가들은 혁신과 성장 전략에 따라 PHM 시장의 50개 이상의 미국 회사를 평가했습니다. Health Catalyst는 사용자 맞춤형 구성, 사전 구축된 규칙 엔진 및 우수한 데이터 관리 기능으로 제3자 PHM IT 이니셔티브를 혁신한 것으로 강조되었습니다.
CEO Dan Burton은 혁신과 고객 중심 솔루션을 통해 의료 문제를 해결하겠다는 회사의 약속을 강조하며 가치 기반 치료에 기여하고 있습니다. 보고서는 또 Health Catalyst의 Carevive와 Lumeon의 전략적 인수가 종양 치료 관리 및 환자 통신 능력을 강화했다고 언급했습니다.
산업 분석가 Sagar Mukhekar는 Health Catalyst의 성장과 혁신, 맞춤형 솔루션, 우수한 데이터 관리에 균형 잡힌 초점을 맞춰 PHM 시장의 리더로 자리 잡고 있다고 칭찬했습니다. 회사가 소외된 세그먼트로 확장하는 것은 리더십을 더욱 공고히 합니다.
Health Catalyst (Nasdaq: HCAT), un fournisseur de premier plan de technologies et services de données et d'analytique, a été reconnu comme leader dans le rapport 2024 Frost Radar™: Gestion de la Santé de la Population aux États-Unis par Frost & Sullivan. L'entreprise a été louée pour sa suite innovante dédiée à la santé de la population, qui propose des outils d'évaluation financière et qualité, un support administratif, et des analyses avancées.
Les analystes de Frost & Sullivan ont évalué plus de 50 entreprises américaines sur le marché de la gestion de la santé de la population (PHM) en fonction de leurs stratégies d'innovation et de croissance. Health Catalyst a été mise en avant pour avoir révolutionné les initiatives IT en matière de PHM tierces avec des configurations personnalisées, un moteur de règles préconstruit, et des capacités avancées de gestion des données.
Le PDG Dan Burton a souligné l'engagement de l'entreprise à relever les défis du système de santé par l'innovation et des solutions centrées sur le client, contribuant ainsi aux soins basés sur la valeur. Le rapport a également noté les acquisitions stratégiques de Carevive et Lumeon par Health Catalyst, qui améliorent la gestion des soins oncologiques et les capacités de communication avec les patients.
L'analyste de l'industrie Sagar Mukhekar a salué l'équilibre de Health Catalyst entre croissance et innovation, solutions personnalisées, et gestion supérieure des données, positionnant l'entreprise comme un leader sur le marché de la PHM. L'expansion de l'entreprise dans des segments mal desservis renforce encore sa position de leader.
Health Catalyst (Nasdaq: HCAT), ein führender Anbieter von Daten- und Analysesoftware sowie -diensten, wurde im Bericht 2024 Frost Radar™: US Population Health Management von Frost & Sullivan als Marktführer anerkannt. Das Unternehmen wurde für seine innovative Population Health Suite gelobt, die finanzielle und qualitative Benchmarking-Tools, administrative Unterstützung und fortgeschrittene Analytik bietet.
Analysten von Frost & Sullivan bewerteten über 50 US-Unternehmen im PHM-Markt auf Grundlage ihrer Innovations- und Wachstumsstrategien. Health Catalyst wurde hervorgehoben, weil es IT-Initiativen zur Bevölkerungs-Gesundheitsverwaltung von Drittanbietern mit individuellen Konfigurationen, einer vorgefertigten Regel-Engine und überlegenen Datenmanagement-Fähigkeiten revolutioniert hat.
CEO Dan Burton betonte das Engagement des Unternehmens, Herausforderungen im Gesundheitswesen durch Innovation und kundenorientierte Lösungen zu begegnen, was zur wertbasierten Versorgung beiträgt. Der Bericht erwähnte auch die strategischen Übernahmen von Carevive und Lumeon durch Health Catalyst, die die Managementfähigkeiten in der Onkologie und die Patientenkommunikation verbessern.
Branchenanalyst Sagar Mukhekar lobte Health Catalysts ausgewogenes Augenmerk auf Wachstum und Innovation, maßgeschneiderte Lösungen und überlegene Datenverwaltung und positionierte das Unternehmen als Marktführer im PHM-Bereich. Die Expansion des Unternehmens in unterversorgte Segmente festigt seine Führungsposition weiter.
- None.
- None.
Frost & Sullivan analysts assessed more than 50 companies in
Health Catalyst received recognition as a leader in the industry for its Population Health suite, which provides clients with financial and quality benchmarking tools, administrative support, and advanced analytics to enhance care delivery and outcomes.
The report lauded Health Catalyst's optimization efforts: "Health Catalyst revolutionized how third-party PHM IT initiatives are optimized. It offers custom configuration, a pre-built rules engine, and superior data management capabilities to ensure that every PHM initiative is successful."
"Being recognized in the 2024 Frost Radar™: US Population Health Management report reflects Health Catalyst's ongoing commitment to addressing healthcare's most pressing challenges through innovation and client-centric solutions," said Dan Burton, CEO of Health Catalyst. "We are thrilled to contribute to the transition toward value-based care. In line with our multi-decade mission, we are dedicated to equipping healthcare organizations with the tools to facilitate data-informed healthcare improvement, operational efficiency, and ultimately, improved patient outcomes."
The report further highlights Health Catalyst's proactive approach to innovation, addressing pressing industry challenges, and consistently strengthening its portfolio with acquisitions like Carevive and Lumeon. The report noted that these acquisitions enhanced Health Catalyst's capabilities in oncology care management and patient communication, reinforcing Health Catalyst's dedication to meet evolving market demands.
"Health Catalyst, with a balanced focus on growth and innovation, holds a solid position to ensure the success of population health management initiatives through its comprehensive and flexible PHM portfolio that seamlessly accommodates the needs of clients of all sizes with custom configuration, a pre-built rules engine, and superior data management capabilities," said Sagar Mukhekar, Industry Analyst at Frost & Sullivan.
Additionally, Frost & Sullivan analysts commended Health Catalyst's strong commitment to innovation, emphasizing its use of client feedback to keep its solutions closely aligned with industry trends. The company's strategic expansion into underserved segments, including ambulatory practices and smaller healthcare organizations, further solidifies its leadership in the PHM market.
About Health Catalyst
Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.
Media Contact:
Amanda Flanders
Senior Vice President of Marketing and Communications
media@healthcatalyst.com
808.743.1781
View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-recognized-as-a-leader-in-frost--sullivans-2024-us-population-health-management-report-302348987.html
SOURCE Health Catalyst
FAQ
What does Health Catalyst's recognition in the 2024 Frost Radar™ report mean?
Why was Health Catalyst recognized in the Frost & Sullivan 2024 report?
How did Health Catalyst enhance its capabilities in oncology care management?
What tools does Health Catalyst's Population Health suite provide?
How does Health Catalyst support value-based care?
What role does client feedback play in Health Catalyst's innovation?
What is the significance of Health Catalyst's expansion into underserved segments?
